Home › Products › Cardiology › Telma CT 80mg/12.5mg Tablet
Telma CT 80mg/12.5mg Tablet
Salt Composition: TELMISARTAN,CHLORTHALIDONE
- Manufacturer: GLENMARK PHARMACEUTICALS LTD
- Pack Size: 15 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 80MG+12.5MG
- Prescription Required
- Storage: Stored in the temperature between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹354.00₹415.78
Inclusive of all taxes
Product Introduction
Telma CT 80mg/12.5mg Tablet is a combination medication containing two active ingredients: telmisartan and chlorthalidone. This combination is used to treat high blood pressure (hypertension). It provides convenience for patients who require both an angiotensin II receptor blocker (ARB) and a diuretic for blood pressure management. Taking a single tablet eliminates the need for multiple pills, simplifying the medication regimen.
Telmisartan belongs to the class of angiotensin II receptor blockers (ARBs). Chlorthalidone is a diuretic that works by removing excess salt and water from the body through increased urine production. Studies suggest that using chlorthalidone in combination with telmisartan may offer kidney protection, particularly in patients with chronic kidney disease and high blood pressure.
Inform your healthcare provider of any other medical conditions, including diabetes, gout, kidney problems, liver problems, electrolyte imbalances, or allergies. Patients with known hypersensitivity or allergy to telmisartan, chlorthalidone, or any other ingredients in the medication should not take Telma CT 80mg/12.5mg Tablet. Patients with severe renal impairment or end-stage renal disease may require dosage adjustments or alternative treatments. Pre-existing electrolyte abnormalities should be corrected before starting treatment, and regular monitoring of electrolyte levels is important during therapy.
Uses
Hypertension Cardiovascular Protection Chronic Kidney Disease Diabetic Nephropathy (kidney condition caused by long-standing diabetes)
How it works
The therapeutic effect of Telma CT 80mg/12.5mg Tablet tablets, a combination medication containing telmisartan and chlorthalidone, is the reduction of high blood pressure (hypertension) through dual mechanisms. Telmisartan works by blocking the action of angiotensin II, a hormone that constricts blood vessels, thereby promoting vasodilation and relaxation of the blood vessels. Chlorthalidone, a diuretic, increases urine production, resulting in the removal of excess salt and water from the body, leading to decreased fluid volume in the blood vessels. Combining these two agents helps in lowering blood pressure, helping to protect against cardiovascular diseases, and potentially providing kidney protection in certain cases.
How to Use
To use Telma CT 80mg/12.5mg Tablet tablets, follow your doctor's instructions precisely. Take the tablets orally with a glass of water, either with or without food. It is important to take the medication simultaneously daily to maintain a consistent routine. Do not adjust the dosage or stop taking the medication without consulting your healthcare professional.
Side Effects
Telma CT 80mg/12.5mg Tablet medicine causes some side effects like all medications, although not everyone will experience them. Serious: Allergic reactions (e.g., swelling of the face, lips, tongue, or throat, difficulty breathing, rash) Severe dizziness Lightheadedness Fainting High potassium levels (muscle weakness, irregular heartbeat) Liver problems (yellowing of the skin or eyes, dark urine, abdominal pain) Common: Dizziness Headache Fatigue Increased urination Muscle cramps or weakness Low blood pressure symptoms
Expert Tips
While taking Telma CT 80mg/12.5mg Tablet tablets, it is important to inform your healthcare professional about any existing medical conditions, including kidney or liver problems, diabetes, asthma, or gout, as dose adjustments or alternative treatments may be required. Regularly monitoring blood pressure, electrolyte levels, kidney function, and blood glucose levels is crucial. It is advisable to stay hydrated and maintain a balanced diet with adequate salt intake. If you experience any allergic reactions, difficulty breathing, swelling, or severe side effects, seek immediate medical attention. Finally, always consult your healthcare professional for personalized guidance and adhere to their recommendations throughout treatment.
References
- J Clin Diagn Res et al , The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open-Label Study, [Published on April 2013], [Accessed date 25 June 2023], https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644445/
- HanAll BioPharma Co., Ltd., Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone, [Published on April 2013], [Accessed date 25 June 2023], https://classic.clinicaltrials.gov/ct2/show/NCT01806363
Safety Advice
Pregnancy: unsafe Telma CT 80mg/12.5mg Tablet tablets are generally contraindicated during pregnancy due to potential fetal harm. Both telmisartan and chlorthalidone can cause fetal injury or death when administered to pregnant women.
Lungs: Consult your doctor Telma CT 80mg/12.5mg Tablet tablets are generally considered safe for individuals with normal lung function. However, if you have a pre-existing lung condition or respiratory disorder, it is important to inform your healthcare professional before starting this medication.
Breastfeeding: unsafe Telma CT 80mg/12.5mg Tablet tablets are generally not recommended during breastfeeding. Both telmisartan and chlorthalidone can pass into breast milk and potentially harm the nursing infant.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.